Safety of ustekinumab in adolescent patients with moderate-to-severe plaque psoriasis: real-world evidence from an ongoing European study (NCT03218488).
Emmanuel MahéA GeldhofM JazraP BergmansA AzzabiMarieke Martha Benedicta SeygerPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)